CompuGroup stock holds steady as investors eye recent earnings and digital health growth

Published on 09/03/2026 at 19:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CompuGroup stock is trading quietly on Xetra as of September 3, 2026, while investors focus on the company’s latest earnings trends and its expanding role in European digital health solutions.

Isometrisches 3D-Diagramm digitales Gesundheitsökosystem Vernetzung von Klinik und Praxis — CompuGroup Medical vernetzt Arztpraxen, Apotheken, Labore und Krankenhäuser in einer digitalen Wertschöpfungskette, DE000A288904, Illustration mit AI erstellt.

CompuGroup Medical SE & Co. KGaA (ISIN DE000A288904) stock is trading on Xetra around its recent level as of September 3, 2026, with a market capitalization in the mid-single-digit billion euro range according to current data from German stock portals. For investors, the key reference remains the company’s latest reported quarterly figures for 2026, which show continued growth in its e-health solutions and practice management software across Europe.

Earnings momentum and guidance set the tone

In its most recent available interim report for fiscal year 2026, CompuGroup Medical reported that revenue in the latest quarter grew compared with the same period of the previous year, driven largely by recurring software and service contracts with medical practices, hospitals and laboratories. The company’s operating result and net profit also improved year on year, reflecting efficiency gains and scale effects in its software platforms. While exact figures and margins vary by segment, the current reporting confirms that digital health demand continues to underpin the group’s financial performance.

Relative to historical levels, this marks a continuation of the trend that was already visible in the previous fiscal year. Historical data for fiscal year 2024 showed that CompuGroup Medical had increased revenue and earnings compared with 2023, with recurring revenues forming a growing share of total sales. Against this backdrop, the latest quarterly figures for 2026 signal that the company is maintaining its growth trajectory in core segments such as ambulatory information systems, hospital information systems and pharmacy software.

Digital health focus and European footprint

CompuGroup Medical is one of the leading providers of e-health solutions in Europe, with a strong presence in Germany, where the stock is traded on Xetra and is closely followed by investors interested in the healthcare technology segment. The company’s software platforms connect doctors, hospitals, pharmacies and laboratories, aiming to make patient data and workflows more efficient and secure. This positioning enables CompuGroup Medical to benefit from ongoing digitization initiatives in national healthcare systems, including electronic prescriptions, digital patient records and telemedicine services.

For the current year 2026, CompuGroup Medical’s business continues to be supported by long-term contracts and regulatory-driven demand for interoperable health IT systems. The company’s guidance, as reflected in its latest investor communications, points to further revenue growth and stable to improving profitability, underpinned by investments in cloud-based software, data analytics and interfaces to national e-health infrastructures. Investors are paying attention to how these investments translate into recurring revenue and margin development over the coming quarters.

Go deeper

CompuGroup Medical stock and key figures

Investors can find more detailed information on CompuGroup Medical’s stock performance and financial reports via the dedicated topic page and the company’s investor relations section.

More CompuGroup Medical news Investor Relations

Representative product: practice management software

A key example of CompuGroup Medical’s product portfolio is its practice management software for physicians and medical centers, which supports appointment scheduling, billing, documentation and communication with pharmacies and laboratories. This software is typically sold as a subscription, generating recurring revenue that contributes to the company’s stable cash flow. In recent reporting periods, CompuGroup Medical has highlighted growth in the installed base of such solutions, reflecting both new customer wins and upgrades among existing users as healthcare providers modernize their IT infrastructure.

CompuGroup stock on Xetra

CompuGroup Medical stock is listed on Xetra in Germany, where it trades in euros and is classified within the healthcare technology and software segment. As of September 3, 2026, the stock price and market capitalization data available from German stock portals show the company firmly positioned among mid-cap healthcare technology players, with trading activity reflecting ongoing interest in digital health and e-health solutions.